Abstract
Sera from selected patients with Lyme disease in different stages were used to passively immunize mice against Borrelia burgdorferi challenge to determine if human antibodies could protect the animals from infection. Sera from 2 patients with late-stage Lyme disease that contained strong antibody reactivity to proteins in B. burgdorferi lysates, including antibodies to the outer surface proteins (Osps) A and B, partly protected mice from infection after challenge with a small inoculum (102) of B. burgdorferi. Mice immunized with sera from either of these 2 patients developed significantly fewer infections from the borreliae (patient 1 serum, 5%; patient 2 serum, 25%) relative to control mice (patient 1 serum, 90%; patient 2 serum, 74%). In contrast, sera from 2 patients with early or late Lyme disease that lacked antibodies reactive to OspA and OspB did not confer protection. Immunity appeared to be related, at least in part, to the presence of a strong humoral response to the Osps. These results suggest that during prolonged infection, some patients develop an immune response that may be partly protective against reinfection with B. burgdorferi. Therefore, although most patients do not mount a strong humoral response to the Osps during natural infection, vaccination with an Osp may elicit protective immunity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 568-574 |
| Number of pages | 7 |
| Journal | Journal of Infectious Diseases |
| Volume | 169 |
| Issue number | 3 |
| State | Published - Mar 1994 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Immunology
- Public Health, Environmental and Occupational Health
Cite this
Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. / Fikrig, Erol; Bockenstedt, Linda K.; Barthold, Stephen W; Chen, Manchuan; Tao, Hong; Ali-Salaam, Pia; Telford, Sam R.; Flavell, Richard A.
In: Journal of Infectious Diseases, Vol. 169, No. 3, 03.1994, p. 568-574.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis
AU - Fikrig, Erol
AU - Bockenstedt, Linda K.
AU - Barthold, Stephen W
AU - Chen, Manchuan
AU - Tao, Hong
AU - Ali-Salaam, Pia
AU - Telford, Sam R.
AU - Flavell, Richard A.
PY - 1994/3
Y1 - 1994/3
N2 - Sera from selected patients with Lyme disease in different stages were used to passively immunize mice against Borrelia burgdorferi challenge to determine if human antibodies could protect the animals from infection. Sera from 2 patients with late-stage Lyme disease that contained strong antibody reactivity to proteins in B. burgdorferi lysates, including antibodies to the outer surface proteins (Osps) A and B, partly protected mice from infection after challenge with a small inoculum (102) of B. burgdorferi. Mice immunized with sera from either of these 2 patients developed significantly fewer infections from the borreliae (patient 1 serum, 5%; patient 2 serum, 25%) relative to control mice (patient 1 serum, 90%; patient 2 serum, 74%). In contrast, sera from 2 patients with early or late Lyme disease that lacked antibodies reactive to OspA and OspB did not confer protection. Immunity appeared to be related, at least in part, to the presence of a strong humoral response to the Osps. These results suggest that during prolonged infection, some patients develop an immune response that may be partly protective against reinfection with B. burgdorferi. Therefore, although most patients do not mount a strong humoral response to the Osps during natural infection, vaccination with an Osp may elicit protective immunity.
AB - Sera from selected patients with Lyme disease in different stages were used to passively immunize mice against Borrelia burgdorferi challenge to determine if human antibodies could protect the animals from infection. Sera from 2 patients with late-stage Lyme disease that contained strong antibody reactivity to proteins in B. burgdorferi lysates, including antibodies to the outer surface proteins (Osps) A and B, partly protected mice from infection after challenge with a small inoculum (102) of B. burgdorferi. Mice immunized with sera from either of these 2 patients developed significantly fewer infections from the borreliae (patient 1 serum, 5%; patient 2 serum, 25%) relative to control mice (patient 1 serum, 90%; patient 2 serum, 74%). In contrast, sera from 2 patients with early or late Lyme disease that lacked antibodies reactive to OspA and OspB did not confer protection. Immunity appeared to be related, at least in part, to the presence of a strong humoral response to the Osps. These results suggest that during prolonged infection, some patients develop an immune response that may be partly protective against reinfection with B. burgdorferi. Therefore, although most patients do not mount a strong humoral response to the Osps during natural infection, vaccination with an Osp may elicit protective immunity.
UR - http://www.scopus.com/inward/record.url?scp=0028008686&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028008686&partnerID=8YFLogxK
M3 - Article
C2 - 8158028
AN - SCOPUS:0028008686
VL - 169
SP - 568
EP - 574
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
SN - 0022-1899
IS - 3
ER -